Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

General Dermatology

Absolute Psoriasis Area and Severity Index as a valuable marker to determine initial treatment response in psoriasis patients treated with guselkumab in routine clinical care

Dermatologic Therapy | Dec 03, 2021 General Dermatology

Clinicopathological characteristics related to etiologies of erythema nodosum: A 10-year retrospective study

Clinical, Cosmetic and Investigational Dermatology | Dec 03, 2021 General Dermatology

Site- and autoantigen-specific characteristics of mucous membrane pemphigoid

JAMA | Dec 02, 2021 General Dermatology

Patient-led surveillance after treatment of localized melanoma

JAMA | Dec 02, 2021 General Dermatology

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumor necrosis factor inhibitors: Results through one year of a phase IIIb, randomized, controlled study (COSMOS)

Annals of Rheumatic Diseases | Dec 01, 2021 General Dermatology

The comparison of demographics and comorbidities of female pattern hair loss according to the clinical subtype and stage

Journal of the American Academy of Dermatology | Dec 01, 2021 General Dermatology

Early localized vitiligo, a medical emergency: Long term follow up study

Dermatologic Therapy | Dec 01, 2021 General Dermatology

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomized, double-blind, phase 3 KEEPsAKE 2 trial

Annals of Rheumatic Diseases | Nov 26, 2021 General Dermatology

Assessment of changes in color and size of vitiligo lesions during treatment with narrow band ultraviolet B

Journal of Cosmetic Dermatology | Nov 26, 2021 General Dermatology

Risk of progression to autoimmune disease in severe drug eruption: Risk factors and the factor-guided stratification

Journal of Investigative Dermatology | Nov 25, 2021 General Dermatology

« Prev 1 … 4 5 6 7 8 … 306 Next »

Absolute Psoriasis Area and Severity Index as a valuable marker to determine initial treatment response in psoriasis patients treated with guselkumab in routine clinical care

Clinicopathological characteristics related to etiologies of erythema nodosum: A 10-year retrospective study

Site- and autoantigen-specific characteristics of mucous membrane pemphigoid

Patient-led surveillance after treatment of localized melanoma

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumor necrosis factor inhibitors: Results through one year of a phase IIIb, randomized, controlled study (COSMOS)

The comparison of demographics and comorbidities of female pattern hair loss according to the clinical subtype and stage

Early localized vitiligo, a medical emergency: Long term follow up study

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomized, double-blind, phase 3 KEEPsAKE 2 trial

Assessment of changes in color and size of vitiligo lesions during treatment with narrow band ultraviolet B

Risk of progression to autoimmune disease in severe drug eruption: Risk factors and the factor-guided stratification

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Absolute Psoriasis Area and Severity Index as a valuable marker to determine initial treatment response in psoriasis patients treated with guselkumab in routine clinical care

Clinicopathological characteristics related to etiologies of erythema nodosum: A 10-year retrospective study

Site- and autoantigen-specific characteristics of mucous membrane pemphigoid

Patient-led surveillance after treatment of localized melanoma

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumor necrosis factor inhibitors: Results through one year of a phase IIIb, randomized, controlled study (COSMOS)

The comparison of demographics and comorbidities of female pattern hair loss according to the clinical subtype and stage

Early localized vitiligo, a medical emergency: Long term follow up study

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomized, double-blind, phase 3 KEEPsAKE 2 trial

Assessment of changes in color and size of vitiligo lesions during treatment with narrow band ultraviolet B

Risk of progression to autoimmune disease in severe drug eruption: Risk factors and the factor-guided stratification

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Select Specialty

Select Topic